ArticleFrontiers in oncology2022

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx

Yinjuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.